ClinicalTrials.gg

Program

Targeted CEA CAR-T

Its studies are mostly in Lung Neoplasms, led by Chongqing Precision Biotech.

Furthest: phase 1, since Dec 12, 20244 company-led studies, 4 open or runningNext primary completion: Dec 31, 2026 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Chongqing Precision Biotech44 open or runningphase 1since Dec 12, 2024Dec 12, 2024Dec 31, 2026phase 1 · NCT06768151

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Dec 12, 2024First study: phase 1 study in Advanced Lung CancerFirst studyNCT06768151 · 48 planned · China
  2. Mar 24, 2025Phase 1 study in Advanced Lung CancerNCT06903117 · 60 planned · China
  3. Apr 11, 2025Phase 1 study in Advanced Lung CancerNCT06945523 · 60 planned · China
  4. May 16, 2025Phase 1 study in Advanced Lung CancerNCT06992583 · 60 planned · China

Ahead

  1. Dec 31, 2026Primary completion: phase 1 study in Advanced Lung CancerNCT06768151
  2. Dec 31, 2027Primary completion: phase 1 study in Advanced Lung CancerNCT06945523
  3. Dec 31, 2027Primary completion: phase 1 study in Advanced Lung CancerNCT06903117
  4. Feb 29, 2028Primary completion: phase 1 study in Advanced Lung CancerNCT06992583

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06992583Advanced Lung Cancer · China1RecruitingFeb 29, 202860
NCT06945523Advanced Lung Cancer · China1RecruitingDec 31, 202760
NCT06903117Advanced Lung Cancer · China1RecruitingDec 31, 202760
NCT06768151Advanced Lung Cancer · China1RecruitingDec 31, 202648

How it is read

Names in the registry

  • “Targeted CEA CAR-T”, 8 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.